PROBUCOL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN HYPERCHOLESTEROLEMIA

被引：142

作者：

BUCKLEY, MMT

GOA, KL

PRICE, AH

BROGDEN, RN

机构：

来源：

DRUGS | 1989年 / 37卷 / 06期

关键词：

D O I：

10.2165/00003495-198937060-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：761 / 800

页数：40

共 145 条

[11]

BEAUMONT V, 1980, DIET DRUGS ATHEROSCL, P209

[12] INFLUENCE OF PROBUCOL ADMINISTRATION ON LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEINS IN NORMOLIPEMIC MALES [J].

BERG, A ;

FREY, I ;

BAUMSTARK, M ;

KEUL, J .

ATHEROSCLEROSIS, 1988, 72 (01) :49-54

[13]

BERG A, 1988, 8 INT S ATH ROM

[14]

BERTOLINI S, 1983, IRCS MED SCI-BIOCHEM, V11, P933

[15] DISCREPANCIES BETWEEN THE OUTCOME OF ANIMAL AND HUMAN STUDIES ON THE MODE OF ACTION OF PROBUCOL [J].

BEYNEN, AC .

ATHEROSCLEROSIS, 1986, 61 (03) :249-251

[16]

BOYDEN TW, 1981, J CLIN PHARMACOL, V1, P48

[17] PROLONGATION OF THE QT INTERVAL INDUCED BY PROBUCOL - DEMONSTRATION OF A METHOD FOR DETERMINING QT INTERVAL CHANGE INDUCED BY A DRUG [J].

BROWNE, KF ;

PRYSTOWSKY, EN ;

HEGER, JJ ;

CERIMELE, BJ ;

FINEBERG, N ;

ZIPES, DP .

AMERICAN HEART JOURNAL, 1984, 107 (04) :680-684

[18]

BUXTORF JC, 1985, SEM HOP PARIS, V61, P837

[19] ANTIATHEROGENIC EFFECT OF PROBUCOL UNRELATED TO ITS HYPOCHOLESTEROLEMIC EFFECT - EVIDENCE THAT ANTIOXIDANTS INVIVO CAN SELECTIVELY INHIBIT LOW-DENSITY-LIPOPROTEIN DEGRADATION IN MACROPHAGE-RICH FATTY STREAKS AND SLOW THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J].

CAREW, TE ;

SCHWENKE, DC ;

STEINBERG, D .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7725-7729

[20]

CARMENA R, 1980, DIET DRUGS ATHEROSCL, P215

← 1 2 3 4 5 6 7 8 9 10 →